s6y
Company name or ticker
Search
Prelude Therapeutics Inc
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Filed
Monday, March 10, 2025
Accession number
0000950170-25-035930
Documents
S-8
S-8
EX-5.1
EX-5.1
EX-23.2
EX-23.2
EX-FILING FEES
EX-FILING FEES
On sec.gov
Filing index
All files
Complete submission text
SGML header